Hormonal
Aerobic exercise training improves systemic glucose homeostasis in individuals with type 2 diabetes by decreasing HbA1c and fasting blood glucose levels.
If you have type 2 diabetes, regular aerobic exercise is a powerful tool to lower your HbA1c and blood sugar. You don't need to spend hours exercising; studies show that walking for just 30 minutes, three times a week, can significantly improve your markers. Start with what you can sustain and gradually increase the duration or intensity.
Aerobic exercise training is well-known for its ability to improve systemic glucose control in both individuals and animals with type 2 diabetes. Studies in both men and women with type 2 diabetes have demonstrated the following beneficial effects: (1) 8 weeks of aerobic walking (30 min/day, 3 days/week) decreased HbA1c levels ~18% [8]; (2) 12 weeks of bicycle training (60 min/day, 3 days/week) decreased fasted blood glucose levels ~14% [2]...
Why this rating
Review of multiple human and rodent studies showing consistent beneficial effects, though specific protocols vary.
Source
Regulation of Skeletal Muscle Glucose Transport and Glucose Metabolism by Exercise Training
Parker L. Evans et al. · Nutrients · 2019
DOI 10.3390/nu11102432
More from this paper
- Resistance exercise training improves systemic glucose homeostasis in individuals with type 2 diabetes by decreasing HbA1c and fasting blood glucose levels.Good
- Aerobic exercise training increases skeletal muscle GLUT4 protein levels, which enhances insulin-stimulated muscle glucose disposal.Good
- Resistance exercise training increases glucose transport into skeletal muscle, but unlike aerobic training, it does not consistently increase GLUT4 protein levels.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →